The Olive Oil Monophenolic Secoiridoid Ligstroside Aglycone Suppresses Melanoma Progression by Targeting the BRAF Signaling Pathway
Melanoma is among the most abundant malignancies in the US and worldwide. Ligstroside aglycone (LA) is a rare extra-virgin olive oil-derived monophenolic secoiridoid with diverse bioactivities. LA dose–response screening at the NCI 60 cancer cells panel identified the high sensitivity of the Malme-3...
Saved in:
Main Authors: | Md Ashiq Mahmud, Abu Bakar Siddique, Afsana Tajmim, Judy Ann King, Khalid A. El Sayed |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/30/1/139 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Frecuencia de la inmunosupresión de BRAF V600E en ameloblastomas: Un análisis multi-insituticional de 86 casos en América Latina
by: Lauren Frenzel Schuch, et al.
Published: (2024-12-01) -
RATIONAL DRUG DESIGN OF POTENT V600E-BRAF KINASE INHIBITORS THROUGH MOLECULAR DOCKING SIMULATION
by: Bello Abdullahi Umar, et al.
Published: (2019-12-01) -
Frequent mutation of K-RAS in addition to BRAF V600E in Ameloblastoma – An immunohistochemical study
by: Aishwariya Mohanty, et al.
Published: (2024-06-01) -
BRAF inhibitor monotherapy in BRAFV600E-mutated pediatric low-grade glioma: a single center’s experience
by: S. S. McThenia, et al.
Published: (2025-01-01) -
Primary mucoepidermoid carcinoma of the thyroid with concomitant MAML2 gene rearrangement and BRAF V600E mutation – A case report
by: Frederica Loghides, et al.
Published: (2024-03-01)